NCT01294709: A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014) |
|
|
| Completed | 1 | 64 | NA | telcagepant, MK-0974, Placebo to telcagepant | Merck Sharp & Dohme LLC | Angina Pectoris, Coronary Heart Disease, Calcitonin Gene-related Peptide Receptor | 02/09 | 03/09 | | |
